Kalshi has been warned of potential charges over new-product notifications, Reuters reported on 10 November, citing a person familiar with the matter. The reported warning comes from the Commodity Futures Trading Commission, the federal agency at the centre of the exchange's regulatory model.
The report referred to dozens of products. Kalshi described a procedural error involving a handful of contract submissions, many not live, and said it was addressing the issue.
This remains a report of prospective enforcement, rather than an established breach.
The commercial significance extends beyond the immediate dispute. An exchange seeking the advantages of a national derivatives framework also accepts detailed obligations to the regulator overseeing it. Those two features belong to the same business model.
A federal relationship shaped by litigation
Kalshi's relationship with the CFTC has already included permission to operate, disagreement over products and a consequential court challenge.
In November 2020, the commission designated KalshiEX LLC as a contract market. Its announcement expressly tied that status to continuing compliance with the Commodity Exchange Act and applicable CFTC regulations.
That designation established the exchange's place within the federal system. Individual contracts could still raise questions under the rules governing their listing.
In September 2023, the CFTC disapproved Kalshi's congressional-control contracts. The proposed products concerned which political party would control a chamber of Congress. The commission argued that the contracts fell within categories subject to its special public-interest review.
Kalshi challenged that decision. In September 2024, US District Judge Jia M. Cobb ruled that the commission had exceeded its statutory authority in the case. Her opinion addressed the congressional-control contracts and the reach of the relevant statutory provision.
The scope matters. Winning that dispute removed a particular regulatory obstacle. The exchange's continuing duties under its federal designation remained part of operating the business.
For the industry, this history illustrates how several legal questions can sit behind the phrase federally regulated: the exchange's status, the treatment of a particular product and the process followed when listing it.
The obligations behind self-certification
Event contracts link a payment to a specified outcome. The contract's terms determine what counts as that outcome and how it will be established. Those details are central to what participants are trading.
US regulation allows designated contract markets to list products through self-certification. Under the standard route in Regulation 40.2(a), a submission must reach the CFTC by the opening of business on the business day before listing.
It must include the contract terms, intended listing date and certification of compliance with the law and regulations. The filing also needs supporting explanation and analysis, and the exchange must publish notice of the pending certification and a copy of its submission, subject to confidentiality provisions.
The process allows an exchange to move without obtaining a separate affirmative approval for every product using that route. It places responsibility on the exchange for the certification and its supporting material. The rules also allow the regulator to request further evidence of compliance.
These are the general requirements that explain why product submissions matter. The reported warning does not establish which particular obligations, if any, Kalshi breached.
From a business perspective, the underlying task is maintaining an accurate connection between what the exchange has filed, what it has published and what customers can trade. That connection becomes harder to manage as products and revisions multiply.
Jurisdiction and compliance are separate questions
The latest development follows the CFTC's 5 November interpretation of impartial-access requirements.
The commission said designated contract markets must remove domestic geographic restrictions that violate those requirements within 30 days, or explain why compliance is not feasible. Its statement also addressed access through intermediaries. Chairman Michael S. Selig linked the interpretation to the operation of uniform national derivatives markets.
We examined that intervention in CFTC's 30-day access demand deepens prediction markets dispute, including the difficulties created by competing access requirements.
The new reporting concerns the exchange's relationship with its federal supervisor. The access dispute concerns where and under whose authority trading may be offered. Product-submission duties concern how the exchange exercises its position within the federal system.
The distinction can be set out simply:
| Question | Regulatory issue |
|---|---|
| What status does the exchange hold? | Designation and continuing obligations |
| How does a product reach the market? | The applicable submission and certification process |
| Who can access the market? | Access rules and the relevant legal proceedings |
A regulator can defend the reach of its jurisdiction while scrutinising a business operating within it. In our view, treating those functions as compatible gives a clearer understanding of the sector than judging every intervention as support for, or opposition to, prediction markets.
Product growth needs a reliable record
The attraction of expanding a contract catalogue is straightforward. More relevant markets can give customers additional reasons to use an exchange and create more opportunities to match trading interest.
The operational workload grows with the catalogue. Each product needs defined terms, a reliable process for establishing its outcome and a record of the regulatory route used to list it. Changes need to remain traceable across the exchange's systems and public documents.
Our concern is the gap that can develop between commercial speed and the capacity to document decisions. In any regulated business, a launch process becomes vulnerable if teams cannot consistently establish which version was submitted, when it was submitted and which version customers received.
That is a general management risk, rather than a finding about Kalshi's internal systems. Assessing this particular matter requires evidence about the affected submissions and the applicable requirements.
The distinction is also relevant to partners distributing an exchange's products. They depend on clear information about the products available through their services. A growing catalogue has greater commercial value when the permissions and processes supporting it can be demonstrated reliably.
What would change the assessment
A public enforcement document would provide a much firmer basis for judging the matter. It could identify the affected products, alleged failures, relevant dates and remedy sought. The company's detailed response would then help establish what remains disputed.
Those details would distinguish a limited submission problem from any wider control issue. The severity of the outcome should follow the evidence.
For the prediction-market industry, the wider lesson is that federal oversight is an operating commitment. Businesses using that framework need the systems and staff to meet its requirements as their products develop.
Our view is that the durability of the model will depend partly on that ordinary discipline. Legal victories can open opportunities; reliable day-to-day controls help a company keep serving the market it has built. The reported warning brings that less visible part of Kalshi's business into the foreground.